LRPPRC
Leucine-rich PPR motif-containing protein, mitochondrial
Also known as: GP130, LPPRC_HUMAN, LRP130, LSFC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42704
- Gene
- LRPPRC
- Ensembl
- ENSG00000138095
- Chromosome
- 2
- Canonical length
- 1394 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Acrosome,Mid piece,End piece
OverviewNCBI Gene
This gene encodes a leucine-rich protein that has multiple pentatricopeptide repeats (PPR). The precise role of this protein is unknown but studies suggest it may play a role in cytoskeletal organization, vesicular transport, or in transcriptional regulation of both nuclear and mitochondrial genes. The protein localizes primarily to mitochondria and is predicted to have an N-terminal mitochondrial targeting sequence. Mutations in this gene are associated with the French-Canadian type of Leigh syndrome. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
1394 residues, UniProt reviewed canonical sequence.
>P42704|LRPPRC
1 MAALLRSARW LLRAGAAPRL PLSLRLLPGG PGRLHAASYL PAARAGPVAG GLLSPARLYA
61 IAAKEKDIQE ESTFSSRKIS NQFDWALMRL DLSVRRTGRI PKKLLQKVFN DTCRSGGLGG
121 SHALLLLRSC GSLLPELKLE ERTEFAHRIW DTLQKLGAVY DVSHYNALLK VYLQNEYKFS
181 PTDFLAKMEE ANIQPNRVTY QRLIASYCNV GDIEGASKIL GFMKTKDLPV TEAVFSALVT
241 GHARAGDMEN AENILTVMRD AGIEPGPDTY LALLNAYAEK GDIDHVKQTL EKVEKSELHL
301 MDRDLLQIIF SFSKAGYPQY VSEILEKVTC ERRYIPDAMN LILLLVTEKL EDVALQILLA
361 CPVSKEDGPS VFGSFFLQHC VTMNTPVEKL TDYCKKLKEV QMHSFPLQFT LHCALLANKT
421 DLAKALMKAV KEEGFPIRPH YFWPLLVGRR KEKNVQGIIE ILKGMQELGV HPDQETYTDY
481 VIPCFDSVNS ARAILQENGC LSDSDMFSQA GLRSEAANGN LDFVLSFLKS NTLPISLQSI
541 RSSLLLGFRR SMNINLWSEI TELLYKDGRY CQEPRGPTEA VGYFLYNLID SMSDSEVQAK
601 EEHLRQYFHQ LEKMNVKIPE NIYRGIRNLL ESYHVPELIK DAHLLVESKN LDFQKTVQLT
661 SSELESTLET LKAENQPIRD VLKQLILVLC SEENMQKALE LKAKYESDMV TGGYAALINL
721 CCRHDKVEDA LNLKEEFDRL DSSAVLDTGK YVGLVRVLAK HGKLQDAINI LKEMKEKDVL
781 IKDTTALSFF HMLNGAALRG EIETVKQLHE AIVTLGLAEP STNISFPLVT VHLEKGDLST
841 ALEVAIDCYE KYKVLPRIHD VLCKLVEKGE TDLIQKAMDF VSQEQGEMVM LYDLFFAFLQ
901 TGNYKEAKKI IETPGIRARS ARLQWFCDRC VANNQVETLE KLVELTQKLF ECDRDQMYYN
961 LLKLYKINGD WQRADAVWNK IQEENVIPRE KTLRLLAEIL REGNQEVPFD VPELWYEDEK
1021 HSLNSSSAST TEPDFQKDIL IACRLNQKKG AYDIFLNAKE QNIVFNAETY SNLIKLLMSE
1081 DYFTQAMEVK AFAETHIKGF TLNDAANSRL IITQVRRDYL KEAVTTLKTV LDQQQTPSRL
1141 AVTRVIQALA MKGDVENIEV VQKMLNGLED SIGLSKMVFI NNIALAQIKN NNIDAAIENI
1201 ENMLTSENKV IEPQYFGLAY LFRKVIEEQL EPAVEKISIM AERLANQFAI YKPVTDFFLQ
1261 LVDAGKVDDA RALLQRCGAI AEQTPILLLF LLRNSRKQGK ASTVKSVLEL IPELNEKEEA
1321 YNSLMKSYVS EKDVTSAKAL YEHLTAKNTK LDDLFLKRYA SLLKYAGEPV PFIEPPESFE
1381 FYAQQLRKLR ENSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRPPRC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 46 nTPM
- tongue: 35 nTPM
- kidney: 24 nTPM
- heart muscle: 23 nTPM
- pancreas: 21 nTPM
- colon: 18 nTPM
Single-cell type
- erythrocyte progenitors: 353 nCPM
- sertoli cells: 275 nCPM
- megakaryocyte-erythroid progenitors: 208 nCPM
- choroid plexus epithelial cells: 206 nCPM
- megakaryocyte progenitors: 183 nCPM
- myonuclei: 179 nCPM
Immune cell
- MAIT T-cell: 19 nTPM
- myeloid DC: 18 nTPM
- naive CD4 T-cell: 17 nTPM
- naive B-cell: 17 nTPM
- total PBMC: 16 nTPM
- memory B-cell: 16 nTPM
Brain region
- choroid plexus: 69 nTPM
- white matter: 48 nTPM
- pons: 48 nTPM
- cerebellum: 46 nTPM
- hypothalamus: 46 nTPM
- thalamus: 45 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LRPPRC.
Disease | AllUniProt
Conditions LRPPRC is implicated in, by any mechanism.
- Mitochondrial complex IV deficiency, nuclear type 5 (MC4DN5) MIM:220111
Disease | GeneticClinVar
335 pathogenic / likely-pathogenic of 2,374 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type
- LRPPRC-related disorder
- Thyroid cancer, nonmedullary, 1
- Squamous cell carcinoma of the head and neck
- Nonpapillary renal cell carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.93
- DepMap mean gene effect
- -0.62
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagy
- mitochondrial mRNA polyadenylation
- mitochondrial RNA catabolic process
- mitochondrion transport along microtubule
- mRNA transport
- negative regulation of mitochondrial mRNA catabolic process
- regulation of mitochondrial translation
Molecular functions
- beta-tubulin binding
- microtubule binding
- mRNA 3'-UTR binding
- mRNA binding
- RNA binding
- single-stranded DNA binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pentatricopeptide repeat
- Tetratricopeptide-like helical domain superfamily
- PROP1-like, PPR domain
- Pentatricopeptide repeat domain
- Pentacotripeptide-repeat region of PRORP
- Leucine-rich PPR motif-containing protein
- PPR repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRPPRC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRPPRC as an antibody target. Whether an autoantibody or antibody against LRPPRC could matter depends on whether native LRPPRC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRPPRC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRPPRC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...